|
|
| (169 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | + | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | + | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32335367|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response |pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=32333222|t=ä. The genetic sequence, origin, and diagnosis of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32269085|t=ä. Pathogenesis of COVID-19 from a cell biologic perspective |pdf=|usr=}}
| + | |
| − | {{tp|p=32141570|t=2020. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV |pdf=|usr=}}
| + | |
| − | {{tp|p=32141569|t=2020. COVID-19 (Novel Coronavirus 2019) - recent trends |pdf=|usr=}}
| + | |
| − | {{tp|p=32329877|t=2020. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Research tools]]'''
| |
| − | {{tp|p=32142596|t=2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS |pdf=|usr=}}
| |
| − | {{tp|p=32187834|t=2020. ..COVID19: Cytometry and the New Challenge for Global Health |pdf=|usr=}}
| |
| − | {{tp|p=32270412|t=ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2 |pdf=|usr=}}
| |
| | | | |
| − | *
| |
| − | *'''[[Structure of covid19]]'''
| |
| | | | |
| | + | *'''[[Respiration mgmt]]''' |
| | | | |
| − | *'''[[Target binding and uptake]]''' | + | *'''[[Diagnosis (Laboratory)]]''' |
| − | {{tp|p=32220422|t=2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections |pdf=|usr=}}
| + | |
| − | {{tp|p=32336612|t=ä. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | + | |
| | + | *'''[[Diagnosis (other modalities)]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | *'''[[Structure of covid19]]''' |
| | + | |
| | + | |
| | + | *'''[[Target binding and uptake]]''' |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| − | {{tp|p=32271376|t=ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19 |pdf=|usr=}}
| + | |
| | + | |
| | | | |
| | *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| − | *'''[[Immunology]]'''
| |
| − | {{tp|p=32348472|t=ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?|pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Immunology]]''' |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| Zeile 37: |
Zeile 39: |
| | | | |
| | | | |
| − | *'''[[Microvascular]]''' | + | *'''[[Pathobiology]]''' |
| − | *
| + | |
| − | *'''[[Early symptoms]]'''
| + | |
| − | *'''[[Systemic disease, any manifestations]]'''
| + | |
| − | {{tp|p=32160148|t=2020. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32343223|t=2020. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient |pdf=|usr=}}
| + | |
| − | {{tp|p=32298228|t=2020. Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32345526|t=ä. Factors associated with mortality in patients with COVID-19 A quantitative evidence synthesis of clinical and laboratory data |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[ARDS]]''' | + | *'''[[Disease Models]]''' |
| | | | |
| − | *'''[[Pulmonary embolism, coagulation]]'''
| |
| − | {{tp|p=32334995|t=2020. Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32303472|t=ä. Acute pulmonary embolism in a patient with COVID-19 pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32348233|t=2020. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease |pdf=|usr=}}
| |
| − | {{tp|p=32227120|t=ä. Acute pulmonary embolism and COVID-19 pneumonia: a random association?|pdf=|usr=}}
| |
| − | {{tp|p=32338707|t=ä. Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | | | |
| | | | |
| − | *'''[[Hematology]]'''
| |
| − | *'''[[Heart]]'''
| |
| − | {{tp|p=32363381|t=ä. Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?|pdf=|usr=}}
| |
| − | {{tp|p=32227076|t=ä. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32196087|t=ä. SARS-CoV2: should inhibitors of the renin?angiotensin system be withdrawn in patients with COVID-19?|pdf=|usr=}}
| |
| − | {{tp|p=32267502|t=ä. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection |pdf=|usr=}}
| |
| − | {{tp|p=32267494|t=ä. CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32285920|t=ä. Transient complete heart block in a patient with critical COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32285915|t=ä. Typical takotsubo syndrome triggered by SARS-CoV-2 infection |pdf=|usr=}}
| |
| − | {{tp|p=32338706|t=ä. Myocarditis revealing COVID-19 infection in a young patient |pdf=|usr=}}
| |
| − | {{tp|p=32282027|t=ä. COVID-19-related myocarditis in a 21-year-old female patient |pdf=|usr=}}
| |
| − | {{tp|p=32359887|t=ä. SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Early symptoms]]''' |
| | | | |
| | + | *'''[[Systemic disease, any manifestations]]''' |
| | | | |
| | + | *'''[[Co-Infection]]''' |
| | | | |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]''' | + | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32283980|t=2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms |pdf=|usr=}}
| + | |
| − | {{tp|p=32269598|t=2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?|pdf=|usr=}}
| + | |
| − | {{tp|p=32370982|t=ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review |pdf=|usr=}}
| + | |
| − | {{tp|p=32253535|t=ä. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study |pdf=|usr=}}
| + | |
| − | {{tp|p=32328771|t=ä. The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32303881|t=ä. Possible link between anosmia and COVID-19: sniffing out the truth |pdf=|usr=}}
| + | |
| − | {{tp|p=32309267|t=2020. Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered?|pdf=|usr=}}
| + | |
| − | {{tp|p=32329813|t=2020. Defining the burden of olfactory dysfunction in COVID-19 patients |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Dermatology]]'''
| |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| − | {{tp|p=32309266|t=2020. Abdominal Pain: A Real Challenge in Novel COVID-19 Infection |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Kidney, urology]]==
| |
| − | {{tp|p=32299479|t=2020. Acute kidney injury in SARS-CoV-2 infected patients |pdf=|usr=}}
| |
| − | {{tp|p=32197060|t=2020. Rhabdomyolysis as Potential Late Complication Associated with COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Hematology]]''' |
| | | | |
| − | *
| |
| − | *'''[[Pathobiology]]'''
| |
| − | {{tp|p=32294179|t=ä. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications |pdf=|usr=}}
| |
| − | {{tp|p=32293672|t=ä. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts |pdf=|usr=}}
| |
| − | {{tp|p=32350105|t=ä. Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection |pdf=|usr=}}
| |
| − | {{tp|p=32341103|t=2020. Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Disease Models]]'''
| |
| − | {{tp|p=32215622|t=ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility |pdf=|usr=}}
| |
| − | {{tp|p=32378471|t=2020. Animal models for emerging coronavirus: progress and new insights |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Heart]]''' |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | {{tp|p=31859605|t=2020. Genetic manipulation of porcine deltacoronavirus reveals insights into NS6 and NS7 functions: a novel strategy for vaccine design |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *
| + | *'''[[Neurology, ophthalmology, orl]]''' |
| − | *'''[[Diagnosis (Laboratory)]]''' | + | |
| − | {{tp|p=32270412|t=ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32342252|t=ä. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards |pdf=|usr=}}
| + | |
| − | {{tp|p=32329811|t=2020. The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-nCov |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]''' | + | *'''[[Dermatology]]''' |
| − | {{tp|p=32294704|t=ä. Structured thoracic computed tomography report for COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32374802|t=ä. The halo sign as a chest computed tomography finding of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32241244|t=2020. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32285222|t=ä. Three unsuspected CT diagnoses of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32285028|t=2020. Lung Changes on Chest CT During 2019 Novel Coronavirus (COVID-19) Pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32337662|t=ä. Classification of COVID-19 patients from chest CT images using multi-objective differential evolution?based convolutional neural networks |pdf=|usr=}}
| + | |
| − | {{tp|p=32107577|t=ä. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32088847|t=ä. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases |pdf=|usr=}}
| + | |
| − | {{tp|p=32198615|t=ä. The potential added value of FDG PET/CT for COVID-19 pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32166511|t=ä. 18F-FDG PET/CT and COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32350559|t=ä. Is there a role for lung perfusion 99mTc -MAA SPECT/CT to rule out pulmonary embolism in COVID-19 patients with contraindications for iodine contrast?|pdf=|usr=}}
| + | |
| − | {{tp|p=32246209|t=ä. The indispensable role of chest CT in the detection of coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32342191|t=ä. FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32335706|t=ä. CT, 18F FDG-PET/CT and clinical findings before and during early Covid-19 onset in a patient affected by vascular tumour |pdf=|usr=}}
| + | |
| − | {{tp|p=32333071|t=ä. A case of COVID-19 lung infection first detected by 18F FDG PET-CT |pdf=|usr=}}
| + | |
| − | {{tp|p=32303786|t=ä. PET imaging of COVID-19: the target and the number |pdf=|usr=}}
| + | |
| − | {{tp|p=32335426|t=ä. Imaging of Coronavirus Disease 2019: A Chinese Expert Consensus Statement |pdf=|usr=}}
| + | |
| − | {{tp|p=32193037|t=2020. CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity |pdf=|usr=}}
| + | |
| − | {{tp|p=32199142|t=2020. Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings |pdf=|usr=}}
| + | |
| − | {{tp|p=32229322|t=2020. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?|pdf=|usr=}}
| + | |
| − | {{tp|p=32240913|t=2020. High-resolution computed tomography manifestations of COVID-19 infections in patients of different ages |pdf=|usr=}}
| + | |
| − | {{tp|p=32334369|t=2020. Serial CT features in discharged COVID-19 patients with positive RT-PCR re-test |pdf=|usr=}}
| + | |
| − | {{tp|p=32289051|t=2020. COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review |pdf=|usr=}}
| + | |
| − | {{tp|p=32325282|t=2020. Chest CT findings of COVID-19 pneumonia by duration of symptoms |pdf=|usr=}}
| + | |
| − | {{tp|p=32367422|t=ä. Interpretation of CT signs of 2019 novel coronavirus (COVID-19) pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32367421|t=ä. Incidentally discovered COVID-19 pneumonia: the role of diagnostic imaging |pdf=|usr=}}
| + | |
| − | {{tp|p=32367418|t=ä. Imaging features and evolution on CT in 100 COVID-19 pneumonia patients in Wuhan, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32215691|t=ä. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32025790|t=ä. Imaging changes in patients with 2019-nCov |pdf=|usr=}}
| + | |
| − | {{tp|p=32211963|t=ä. Coronavirus disease 2019: initial chest CT findings |pdf=|usr=}}
| + | |
| − | {{tp|p=32193638|t=ä. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review |pdf=|usr=}}
| + | |
| − | {{tp|p=32193637|t=ä. Recommendation of low-dose CT in the detection and management of COVID-2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32072255|t=ä. Outbreak of novel coronavirus (COVID-19): What is the role of radiologists?|pdf=|usr=}}
| + | |
| − | {{tp|p=32055945|t=ä. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32270314|t=ä. What can European radiologists learn from the outbreak of COVID-19 in China? A discussion with a radiologist from Wuhan |pdf=|usr=}}
| + | |
| − | {{tp|p=32346790|t=2020. Coronavirus disease 2019 (COVID-19) imaging reporting and data system (COVID-RADS) and common lexicon: a proposal based on the imaging data of 37 studies |pdf=|usr=}}
| + | |
| − | {{tp|p=32323011|t=ä. Characteristic CT findings distinguishing 2019 novel coronavirus disease (COVID-19) from influenza pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32314058|t=ä. COVID-19 patients and the radiology department ? advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI) |pdf=|usr=}}
| + | |
| − | {{tp|p=32300971|t=ä. A diagnostic model for coronavirus disease 2019 (COVID-19) based on radiological semantic and clinical features: a multi-center study |pdf=|usr=}}
| + | |
| − | {{tp|p=32296940|t=ä. The role of imaging in 2019 novel coronavirus pneumonia (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32291502|t=ä. Evolution of CT findings in patients with mild COVID-19 pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32291501|t=ä. CT features of novel coronavirus pneumonia (COVID-19) in children |pdf=|usr=}}
| + | |
| − | {{tp|p=32279115|t=ä. CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city |pdf=|usr=}}
| + | |
| − | {{tp|p=32217649|t=2020. Clinical and CT features of early stage patients with COVID-19: a retrospective analysis of imported cases in Shanghai, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32196627|t=2020. Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]'''
| |
| − | {{tp|p=32276598|t=2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia |pdf=|usr=}}
| |
| − |
| |
| − | *'''[[Respiration mgmt]]'''
| |
| − | {{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32357995|t=2020. Tracheal intubation in patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32326959|t=2020. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=C7156900|t=2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series |pdf=|usr=}}
| |
| − | {{tp|p=32322959|t=ä. Tracheostomy in the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32314050|t=ä. Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32299867|t=2020. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion |pdf=|usr=}}
| |
| − | {{tp|p=32271455|t=2020. Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report |pdf=|usr=}}
| |
| − |
| |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| − | {{tp|p=32306118|t=ä. COVID-19 in otolaryngologist practice: a review of current knowledge |pdf=|usr=}}
| |
| − | {{tp|p=32352517|t=ä. Anticoagulation in COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32265307|t=ä. Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches |pdf=|usr=}}
| |
| − | {{tp|p=32341111|t=2020. Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers |pdf=|usr=}}
| |
| − | {{tp|p=32269090|t=ä. Managing the supportive care needs of those affected by COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32329880|t=2020. Short Report - Medical nutrition therapy for critically ill patients with COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | *'''[[Gastroenterology, hepatology]]''' |
| | | | |
| | + | *'''[[Kidney, urology]]''' |
| | | | |
| | + | *'''[[The morbid survivor]]''' |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32232395|t=ä. Initial COVID-19 affecting cardiac patients in China |pdf=|usr=}}
| |
| − | {{tp|p=32324223|t=ä. Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence |pdf=|usr=}}
| |
| − | {{tp|p=32324222|t=ä. Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32236478|t=ä. Speculation is not evidence: antihypertensive therapy and COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32286607|t=ä. Might renin?angiotensin system blockers play a role in the COVID-19 pandemic?|pdf=|usr=}}
| |
| − | {{tp|p=32344292|t=2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |pdf=|usr=}}
| |
| − | {{tp|p=32305831|t=ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment |pdf=|usr=}}
| |
| − | {{tp|p=32328850|t=ä. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening |pdf=|usr=}}
| |
| − | {{tp|p=32322046|t=ä. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32296994|t=ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments |pdf=|usr=}}
| |
| − | {{tp|p=C7141546|t=ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
| |
| − | {{tp|p=32345527|t=ä. Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence |pdf=|usr=}}
| |
| − | {{tp|p=32307204|t=ä. Intrapartum care of women with COVID-19: A practical approach |pdf=|usr=}}
| |
| − | {{tp|p=32278619|t=ä. The novel coronavirus (2019-nCoV) in pregnancy: What we need to know |pdf=|usr=}}
| |
| − | {{tp|p=32217650|t=2020. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis |pdf=|usr=}}
| |
| − | {{tp|p=32269089|t=2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32269087|t=ä. Novel Coronavirus Infection in Newborn Babies Under 28 Days in China |pdf=|usr=}}
| |
| − | {{tp|p=32269088|t=2020. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study |pdf=|usr=}}
| |
| − | {{tp|p=32341104|t=2020. Cardiovascular comorbidity and its impact on patients with Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=32350104|t=ä. COVID-19 and Nicotine as a Mediator of ACE-2 |pdf=|usr=}}
| |
| − | {{tp|p=32341101|t=2020. COVID-19 and Smoking Is Nicotine the Hidden Link?|pdf=|usr=}}
| |
| − | {{tp|p=32312864|t=ä. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32279905|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection |pdf=|usr=}}
| |
| | | | |
| − | {{tp|p=32317180|t=ä. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Case reports]]''' | | *'''[[Case reports]]''' |
| − | {{tp|p=32241316|t=ä. Case Report on Early Diagnosis of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32343659|t=2020. A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32160149|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States |pdf=|usr=}}
| |
| | | | |
| − | {{tp|p=32221725|t=ä. Brief report of the first cured 2019-nCoV pneumonia patient in West China Hospital |pdf=|usr=}}
| + | |
| | + | |
| | + | |
| | + | |
| | + | |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32337324|t=2020. The Data set for Patient Information Based Algorithm to Predict Mortality Cause by COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32267826|t=2020. Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand |pdf=|usr=}}
| |
| − | {{tp|p=32208917|t=2020. The different clinical characteristics of corona virus disease cases between children and their families in China ? the character of children with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32269086|t=ä. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China |pdf=|usr=}}
| |
| − | {{tp|p=32139464|t=ä. The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32271459|t=2020. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha |pdf=|usr=}}
| |
| | | | |
| − | *'''[[The morbid survivor]]''' | + | |
| − | {{tp|p=32329589|t=2020. Rehabilitation management of patients with COVID-19 Lessons learned from the first experiences in China |pdf=|usr=}}
| + | *'''[[Registries]]''' |
| − | {{tp|p=32316718|t=2020. Systematic rapid "living" review on rehabilitation needs due to covid-19: update to march 31st 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32293817|t=2020. Rehabilitation and respiratory management in the acute and early post-acute phase "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency |pdf=|usr=}}
| + | |
| − | {{tp|p=32217657|t=ä. Urgent need of a management plan for survivors of COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − | {{tp|p=C7102592|t=ä. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID) |pdf=|usr=}}
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32363880|t=2020. Medical treatment options for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32372695|t=2020. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol |pdf=|usr=}}
| |
| − | {{tp|p=32347925|t=ä. Statin therapy in COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32347923|t=ä. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety |pdf=|usr=}}
| |
| − | {{tp|p=32337546|t=ä. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?|pdf=|usr=}}
| |
| − | {{tp|p=32282032|t=ä. Neprilysin inhibitor?angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients |pdf=|usr=}}
| |
| − | {{tp|p=32285293|t=ä. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV |pdf=|usr=}}
| |
| − | {{tp|p=C7129866|t=ä. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32341100|t=2020. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective |pdf=|usr=}}
| |
| − | {{tp|p=32265310|t=ä. Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32271462|t=2020. Inositol and pulmonary function Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?|pdf=|usr=}}
| |
| − | {{tp|p=32271456|t=2020. Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32271454|t=2020. Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32329881|t=2020. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience |pdf=|usr=}}
| |
| − | {{tp|p=32329879|t=2020. (Naturlal products: )An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections |pdf=|usr=}}
| |
| | | | |
| | | | |
| − |
| |
| − | *'''[[Biophysics of aerosols]]'''
| |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| − | {{tp|p=32241022|t=ä. SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32297915|t=ä. Comment of the potential risks of sexual and vertical transmission of Covid-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32243255|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations |pdf=|usr=}}
| |
| − | {{tp|p=32342724|t=2020. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient |pdf=|usr=}}
| |
| − | {{tp|p=32336661|t=ä. Is there evidence of intra-uterine vertical transmission potential of COVID-19 infection in samples tested by quantitative RT-PCR?|pdf=|usr=}}
| |
| | | | |
| − | *'''[[Passive protective equipment]]'''
| |
| − | {{tp|p=32324531|t=2020. The Practice of Wearing Surgical Masks during the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32284092|t=2020. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols |pdf=|usr=}}
| |
| − | {{tp|p=32282025|t=ä. Donning and doffing of personal protective equipment (PPE) for angiography during the COVID-19 crisis |pdf=|usr=}}
| |
| − | {{tp|p=32248146|t=2020. Protecting healthcare workers from SARS-CoV-2 infection: practical indications |pdf=|usr=}}
| |
| − | {{tp|p=32350103|t=ä. Universal use of face masks for success against COVID-19: evidence and implications for prevention policies |pdf=|usr=}}
| |
| − | {{tp|p=32271461|t=2020. COVID-19: emerging protective measures |pdf=|usr=}}
| |
| − | {{tp|p=32329812|t=2020. Just one more hygiene practice in COVID-19 |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Biophysics of aerosols]]''' |
| | | | |
| − |
| |
| − | *
| |
| − | *'''[[Running your hospital]]'''
| |
| − | {{tp|p=32228737|t=ä. COVID-19 disease emergency operational instructions for Mental Health Departments issued by the Italian Society of Epidemiological Psychiatry |pdf=|usr=}}
| |
| − | {{tp|p=32303485|t=ä. French consensus on management of head and neck cancer surgery during COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32338298|t=ä. The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32232396|t=ä. Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32361812|t=ä. Mental health treatment online during the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32338764|t=ä. A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience |pdf=|usr=}}
| |
| − | {{tp|p=32286606|t=ä. Priorities for Cath labs in the COVID-19 tsunami: Roberto Ferrari and co-authors present a procedure to follow subsequent to the outbreak in Italy |pdf=|usr=}}
| |
| − | {{tp|p=32320040|t=ä. Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective |pdf=|usr=}}
| |
| − | {{tp|p=32242891|t=ä. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel |pdf=|usr=}}
| |
| − | {{tp|p=32285027|t=2020. Breast Cancer Diagnosis, Treatment and Follow-Up During COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32285026|t=2020. Sars-CoV-2 (COVID-19) Outbreak and Breast Cancer Surgery in Turkey |pdf=|usr=}}
| |
| − | {{tp|p=32305011|t=2020. Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?related disease pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32294611|t=2020. A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19?positive patients with cancer |pdf=|usr=}}
| |
| − | {{tp|p=32361628|t=ä. Lessons from the COVID-19 pandemic ? will virtual patient management reshape uro-oncology in Germany?|pdf=|usr=}}
| |
| − | {{tp|p=32302754|t=2020. Managing patients with cancer in the COVID-19 era |pdf=|usr=}}
| |
| − | {{tp|p=32301984|t=ä. The COVID-19 outbreak and its impact on hospitals in Italy: the model of cardiac surgery |pdf=|usr=}}
| |
| − | {{tp|p=32301976|t=ä. Management of elective aortic valve replacement over the long term in the era of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32243318|t=2020. COVID-19: emergency medicine perspectives from Hong Kong |pdf=|usr=}}
| |
| − | {{tp|p=32243317|t=2020. European Society For Emergency Medicine position paper on emergency medical systems? response to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32229768|t=2020. COVID-19: response plan for International Medical Assistance companies |pdf=|usr=}}
| |
| − | {{tp|p=32224710|t=2020. How emergency departments prepare for virus disease outbreaks like COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32205709|t=2020. The challenge of emergency medicine facing the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32345851|t=2020. The emergency department in the COVID-19 era Who are we missing?|pdf=|usr=}}
| |
| − | {{tp|p=32362361|t=ä. Non-SARS CoV2 positive critical patients: sons of a lesser God?|pdf=|usr=}}
| |
| − | {{tp|p=32215677|t=ä. Suggestions for safety and protection control in Department of Nuclear Medicine during the outbreak of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32232520|t=ä. Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020?|pdf=|usr=}}
| |
| − | {{tp|p=32318782|t=ä. Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units |pdf=|usr=}}
| |
| − | {{tp|p=32296886|t=ä. COVID-19 pandemic: guidance for nuclear medicine departments |pdf=|usr=}}
| |
| − | {{tp|p=32296884|t=ä. Nuclear medicine in responding to global pandemic COVID-19?American College of Nuclear Medicine member experience |pdf=|usr=}}
| |
| − | {{tp|p=32303841|t=ä. Lead the way or leave the way: leading a Department of Orthopedics through the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32225137|t=2020. Facing in real time the challenges of the Covid-19 epidemic for rehabilitation |pdf=|usr=}}
| |
| − | {{tp|p=32175719|t=2020. Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine (PRM) physicians activities in Italy An official document of the Italian PRM Society (SIMFER) |pdf=|usr=}}
| |
| − | {{tp|p=32327266|t=ä. Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it?|pdf=|usr=}}
| |
| − | {{tp|p=32264667|t=2020. First impact on services and their preparation "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency |pdf=|usr=}}
| |
| − | {{tp|p=32329593|t=2020. Telemedicine from research to practice during the pandemic "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency |pdf=|usr=}}
| |
| − | {{tp|p=32329592|t=2020. Organization of acute patients transfer to rehabilitation services during COVID-19 crisis |pdf=|usr=}}
| |
| − | {{tp|p=32329590|t=2020. Impact of coronavirus disease 2019 (covid-19) outbreak on rehabilitation services and physical medicine and rehabilitation (PM&R) physicians activities: perspectives from the Spanish experience |pdf=|usr=}}
| |
| − | {{tp|p=32329591|t=2020. Covid-19 and child disabilities: whom to protect and how |pdf=|usr=}}
| |
| − | {{tp|p=32293816|t=2020. The impact of covid-19 on rehabilitation services and activities Letter to the editor in response to official document of SIMFER |pdf=|usr=}}
| |
| − | {{tp|p=32313348|t=ä. Nosocomial infections in psychiatric hospitals during the new coronavirus pneumonia outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32344294|t=2020. Radiology department strategies to protect radiologic technologists against COVID19: Experience from Wuhan |pdf=|usr=}}
| |
| − | {{tp|p=32336627|t=ä. The need of COVID19 free hospitals to maintain cancer care |pdf=|usr=}}
| |
| − | {{tp|p=32359919|t=ä. COVID-19: The European institute of oncology as a hub centre for breast cancer surgery during the pandemic in Milan (Lombardy region, northern Italy) - A screenshot of the first month |pdf=|usr=}}
| |
| − | {{tp|p=32371040|t=ä. Rationalizing breast cancer surgery during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32362468|t=ä. Cancer surgery in a time of COVID-19: Many questions, few certainties |pdf=|usr=}}
| |
| − | {{tp|p=32371041|t=ä. Cancer care under the outbreak of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32336625|t=ä. Coronavirus outbreak: Reorganising the breast unit during a pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32359918|t=2020. Management of Gynaecological oncology diseases during COVID-19 global pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32331984|t=ä. Surgical management of bone and soft tissue sarcomas and skeletal metastases during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32312591|t=ä. Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology |pdf=|usr=}}
| |
| − | {{tp|p=32347329|t=ä. Surgical management of suspected or confirmed SARS-CoV-2 (COVID-19)-positive patients: a model stemming from the experience at Level III Hospital in Emilia-Romagna, Italy |pdf=|usr=}}
| |
| − | {{tp|p=32313969|t=ä. Personal reflections of an emergency general surgeon on the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32303798|t=ä. European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32303451|t=ä. The Need of Research Initiatives Amidst and After the Covid-19 Pandemic: A Message from the Editors of the European Journal of Vascular and Endovascular Surgery |pdf=|usr=}}
| |
| − | {{tp|p=32307223|t=ä. Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: policy and service recommendations |pdf=|usr=}}
| |
| − | {{tp|p=32234102|t=ä. The consequences of the COVID-19 pandemic on mental health and implications for clinical practice |pdf=|usr=}}
| |
| − | {{tp|p=32328761|t=ä. Adapting to a new normal? 5 key operational principles for a radiology service facing the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32356161|t=ä. Important lessons for infection control in radiology departments during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32318843|t=ä. The Radiology Department during the COVID-19 pandemic: a challenging, radical change |pdf=|usr=}}
| |
| − | {{tp|p=32300968|t=ä. Prevention and control measures in radiology department for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32198275|t=2020. More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China |pdf=|usr=}}
| |
| − | {{tp|p=32312865|t=ä. Covid19: minimising risk to healthcare workers during aerosol producing respiratory therapy using an innovative constant flow canopy |pdf=|usr=}}
| |
| − | {{tp|p=32273180|t=ä. What Does COVID-19 Mean for the Pathology-Urology Interaction?|pdf=|usr=}}
| |
| − | {{tp|p=32279903|t=ä. Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32329810|t=2020. In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention?|pdf=|usr=}}
| |
| − | {{tp|p=32362496|t=ä. Urolithiasis Practice Patterns Following the COVID-19 Pandemic: Overview from the EULIS Collaborative Research Working Group |pdf=|usr=}}
| |
| − | {{tp|p=32362498|t=ä. Telemedicine Online Visits in Urology During the COVID-19 Pandemic?Potential, Risk Factors, and Patients? Perspective |pdf=|usr=}}
| |
| − | {{tp|p=32360050|t=2020. VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32349934|t=ä. The Impact of COVID-19 Outbreak on Uro-oncological Practice Across Europe: Which Burden of Activity Are We Facing Ahead?|pdf=|usr=}}
| |
| − | {{tp|p=32349928|t=ä. Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guerin for High-risk Non?muscle-invasive Bladder Cancer During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32349936|t=ä. Balancing the Effects of COVID-19 Against Potential Progression and Mortality in High-risk Prostate Cancer |pdf=|usr=}}
| |
| − | {{tp|p=32349933|t=ä. Widespread Postponement of Functional Urology Cases During the COVID-19 Pandemic: Rationale, Potential Pitfalls, and Future Consequences |pdf=|usr=}}
| |
| − | {{tp|p=32345522|t=ä. COVID-19: Importance of the Awareness of the Clinical Syndrome by Urologists |pdf=|usr=}}
| |
| − | {{tp|p=32349932|t=ä. Surgical Volume, Safety, Drug Administration, and Clinical Trials During COVID-19: Single-center Experience in Shanghai, China |pdf=|usr=}}
| |
| − | {{tp|p=32345523|t=ä. The Shifting Landscape of Genitourinary Oncology During the COVID-19 Pandemic and how Italian Oncologists Reacted: Results from a National Survey |pdf=|usr=}}
| |
| − | {{tp|p=32312544|t=ä. Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32334884|t=ä. Traditional and Virtual Congress Meetings During the COVID-19 Pandemic and the Post-COVID-19 Era: Is it Time to Change the Paradigm?|pdf=|usr=}}
| |
| − | {{tp|p=32331707|t=ä. Impact of the COVID-19 Pandemic on Paediatric Urology Practice in Europe: A Reflection from the European Association of Urology Young Academic Urologists |pdf=|usr=}}
| |
| − | {{tp|p=32303384|t=ä. Endourological Stone Management in the Era of the COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32336644|t=ä. Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32307215|t=ä. Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Passive protective equipment]]''' |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Running your hospital]]''' |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32342698|t=ä. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic |pdf=|usr=}}
| |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| − | {{tp|p=32363492|t=ä. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32371988|t=ä. COVID-19 pandemic: the effects of quarantine on cardiovascular risk |pdf=|usr=}}
| + | |
| − | {{tp|p=32335765|t=ä. Humanistic Epidemiology: Love in the time of cholera, COVID-19 and other outbreaks |pdf=|usr=}}
| + | |
| − | {{tp|p=32317197|t=ä. Health anxiety and behavioural changes of pregnant women during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32339092|t=2020. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore |pdf=|usr=}}
| + | |
| − | {{tp|p=32339091|t=2020. Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan |pdf=|usr=}}
| + | |
| − | {{tp|p=32297932|t=ä. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage |pdf=|usr=}}
| + | |
| − | {{tp|p=32348457|t=ä. Where have the STEMIs gone during COVID-19 lockdown?|pdf=|usr=}}
| + | |
| − | {{tp|p=32318915|t=ä. Vaccine confidence in the time of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32289789|t=ä. The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| − | *'''[[Economic aspects of the status hygienicus]]'''
| |
| − | *'''[[Educational aspects of the status hygienicus]]'''
| |
| − | *
| |
| − | *'''[[Host, vector, one health, atmospheric aspects]]'''
| |
| − | {{tp|p=C7151430|t=ä. Airborne transmission of SARS-CoV-2: the world should face the reality |pdf=|usr=}}
| |
| − | {{tp|p=32363409|t=2020. SARS-CoV-2 spread in Northern Italy: what about the pollution role?|pdf=|usr=}}
| |
| − | {{tp|p=32283458|t=2020. COVID-19 as a factor influencing air pollution?|pdf=|usr=}}
| |
| − | {{tp|p=32268945|t=ä. Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy?? |pdf=|usr=}}
| |
| − | {{tp|p=32361082|t=2020. Food safety issues related to wildlife have not been taken seriously from SARS to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32353790|t=2020. Biomass use and COVID-19: A novel concern |pdf=|usr=}}
| |
| − | {{tp|p=32330766|t=ä. Is temperature reducing the transmission of COVID-19 ?|pdf=|usr=}}
| |
| − | {{tp|p=32202420|t=ä. An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19) |pdf=|usr=}}
| |
| | | | |
| − | {{tp|p=32367256|t=ä. Nuclear medicine services after COVID-19: gearing up back to normality |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Economic aspects of the status hygienicus]]''' |
| | | | |
| | | | |
| − | *'''[[Origin of Covid19]]''' | + | *'''[[Educational aspects of the status hygienicus]]''' |
| − | {{tp|p=32315281|t=2020. Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| + | ---- |
| − | {{tp|p=32315626|t=2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32148173|t=2020. Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination |pdf=|usr=}}
| + | |
| − | {{tp|p=32102621|t=2020. No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32056509|t=2020. HIV-1 did not contribute to the 2019-nCoV genome |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Remission, recurrence and persistence]]''' | + | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| | | | |
| | + | *'''[[Origin of Covid19]]''' |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32323978|t=ä. Letter to the Editor: Wastewater-Based Epidemiology Can Overcome Representativeness and Stigma Issues Related to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32202421|t=ä. Can a Paper-Based Device Trace COVID-19 Sources with Wastewater-Based Epidemiology?|pdf=|usr=}}
| |
| − | {{tp|p=32311865|t=2020. Prevention of exposure and dispersion of COVID-19 using air purifiers: challenges and concerns |pdf=|usr=}}
| |
| − | {{tp|p=32375455|t=2020. Prediction of COVID-19 transmission dynamics using a mathematical model considering behavior changes in Korea |pdf=|usr=}}
| |
| − | {{tp|p=32345002|t=2020. Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32345000|t=2020. Urgent appeal to minimize community health impacts of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32345001|t=2020. Recommendations to the government following the declaration of COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32344999|t=2020. Preparedness and response to community spread of COVID-19 governmental and national recommendations for COVID-19 by the Pan-Academic Action Committee |pdf=|usr=}}
| |
| − | {{tp|p=32344998|t=2020. Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32344997|t=2020. Professional academic organizations on infectious disease Joint Statement on COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32192278|t=2020. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32164053|t=2020. Estimating the reproductive number and the outbreak size of COVID-19 in Korea |pdf=|usr=}}
| |
| − | {{tp|p=32035431|t=2020. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea |pdf=|usr=}}
| |
| − | {{tp|p=32023775|t=2020. An interim review of the epidemiological characteristics of 2019 novel coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32202489|t=ä. Risk of COVID-19 importation to the Pacific islands through global air travel |pdf=|usr=}}
| |
| − | {{tp|p=32100667|t=ä. Passengers destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America |pdf=|usr=}}
| |
| − | {{tp|p=32242790|t=ä. The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32373189|t=2020. Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32352515|t=ä. The battle against COVID-19: mortality in Italy |pdf=|usr=}}
| |
| − | {{tp|p=32255475|t=ä. Denominator matters in estimating COVID-19 mortality rates |pdf=|usr=}}
| |
| − | {{tp|p=32255476|t=ä. COVID-19 experience in Bergamo, Italy |pdf=|usr=}}
| |
| − | {{tp|p=32255477|t=ä. Strategies to control COVID-19 and future pandemics in Africa and around the globe |pdf=|usr=}}
| |
| − | {{tp|p=32352314|t=2020. The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions |pdf=|usr=}}
| |
| − | {{tp|p=32347745|t=ä. Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds |pdf=|usr=}}
| |
| − | {{tp|p=32003000|t=2020. The novel Chinese coronavirus (2019?nCoV) infections: Challenges for fighting the storm |pdf=|usr=}}
| |
| − | {{tp|p=32270413|t=ä. A family cluster of severe acute respiratory syndrome coronavirus 2 infections |pdf=|usr=}}
| |
| − | {{tp|p=32291542|t=ä. The epidemiology and clinical information about COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32306149|t=ä. Covid-19 epidemic in Italy: evolution, projections and impact of government measures |pdf=|usr=}}
| |
| − | {{tp|p=32318914|t=ä. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity |pdf=|usr=}}
| |
| − | {{tp|p=32328991|t=ä. COVID-19 and the need of targeted inverse quarantine |pdf=|usr=}}
| |
| − | {{tp|p=32309108|t=2020. Mathematical prediction of the time evolution of the COVID-19 pandemic in Italy by a Gauss error function and Monte Carlo simulations |pdf=|usr=}}
| |
| − | {{tp|p=32366488|t=2020. Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32269084|t=2020. No association of COVID-19 transmission with temperature or UV radiation in Chinese cities |pdf=|usr=}}
| |
| − | {{tp|p=32299861|t=2020. The influence of preventive strategies on the COVID-2019 epidemic in Shenzhen, China |pdf=|usr=}}
| |
| − | {{tp|p=32139462|t=ä. Epidemiological characteristics of 2019-ncoV infections in Shaanxi, China by February 8, 2020 |pdf=|usr=}}
| |
| − | {{tp|p=32271458|t=2020. A classifier prediction model to predict the status of Coronavirus COVID-19 patients in South Korea |pdf=|usr=}}
| |
| − | {{tp|p=32329878|t=2020. Deep thought of COVID-19 based on Diamond Princess s quarantine and home quarantine |pdf=|usr=}}
| |
| − | {{tp|p=32329814|t=2020. Quarantine hospitals are essential for COVID-19 contention |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]''' | + | |
| − | {{tp|p=32246996|t=ä. The SARS-CoV-2 epidemic: how the Italian public is being informed |pdf=|usr=}}
| + | *'''[[Remission, recurrence and persistence]]''' |
| − | {{tp|p=32292239|t=2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis |pdf=|usr=}}
| + | |
| − | {{tp|p=32252845|t=ä. Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 Epidemic in France |pdf=|usr=}}
| + | |
| − | {{tp|p=32224712|t=2020. COVID-19, a UK perspective |pdf=|usr=}}
| + | |
| − | {{tp|p=32271457|t=2020. Mask crisis during the COVID-19 outbreak |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | + | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | + | |
| | + | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=C7152572|t=ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter |pdf=|usr=}}
| + | |
| − | {{tp|p=32241328|t=ä. Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January?February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users |pdf=|usr=}}
| + | |
| − | {{tp|p=32332201|t=2020. Infodemic and the spread of fake news in the COVID-19-era |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| | + | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| − | {{tp|p=32345850|t=2020. Collateral damage of the COVID-19 outbreak: expression of concern |pdf=|usr=}}
| + | |
| | + | ---- |
| | + | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | *'''[[Current state of coviki.org]]'''
| |
| − | *[[PubMed selected papers unsorted to be listed in contents topics]]
| |
| − | *[[coviki state of development]]
| |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32253375|t=ä. Nutritional management in hospital setting during SARS-CoV-2 pandemic: a real-life experience |pdf=|usr=}}
| |
| − | {{tp|p=32313188|t=ä. Nutrition amid the COVID-19 pandemic: a multi-level framework for action |pdf=|usr=}}
| |
| − | {{tp|p=32286533|t=ä. Nutritional recommendations for CoVID-19 quarantine |pdf=|usr=}}
| |
| − | {{tp|p=32293675|t=ä. Key words to be adopted for COVID-19 research: A return to simple, large, randomized trials |pdf=|usr=}}
| |
| − | {{tp|p=32362362|t=ä. COVID-19: Timing is Important |pdf=|usr=}}
| |
| − | {{tp|p=32361966|t=ä. A safe flight for children through COVID-19 disaster: keeping our mind open!|pdf=|usr=}}
| |
| − | {{tp|p=32362487|t=ä. New Data and the Covid-19 Pandemic Mandate a Rethink of Antiplatelet Strategies in Patients With TIA or Minor Stroke Associated With Atherosclerotic Carotid Stenosis |pdf=|usr=}}
| |
| − | {{tp|p=32271460|t=2020. Coronavirus disease 2019: a bibliometric analysis and review |pdf=|usr=}}
| |
| − | {{tp|p=32196628|t=2020. Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2 Would a rose by another name smell as sweet?|pdf=|usr=}}
| |
| − | {{tp|p=32141586|t=2020. Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches?|pdf=|usr=}}
| |
| | | | |
| | + | |
| | + | *'''[[Research tools]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | | | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[http://www.okaybio.com covid19 antibodies, proteins & reagents] | + | |
| − | *[http://www.reactionbiology.com 700 kinsse assays] | + | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
